In silico Study of the Proteins Involved in the Persistence of Brucella spp
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
BACKGROUND: One of the major problems with Brucella infections is its tendency to become chronic and recurrent, providing a hindrance to the management of this infection. It has been proposed that chronicity is greatly affected by a phenomenon called persistence in bacteria. Several mechanisms are involved in bacterial persistence, including the type II toxin-antitoxin system, the SOS and oxidative and stringent responses.
METHODS: In this in silico study, these persistence mechanisms in Brucella spp. were investigated.
RESULTS: The structure and the interactions between modules involved in these systems were designed, and novel peptides that can interfere with some of these important mechanisms were developed.
CONCLUSION: Since peptide-based therapeutics are a new and evolving field due to their ease of production, we hope that peptides developed in this study, as well as the information about the structure and interactions of modules of persistence mechanisms, can further be used to design drugs against Brucella persister cells in the hope of restraining the chronic nature of Brucellosis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Current drug discovery technologies - 20(2023), 1 vom: 05., Seite e050822207324 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Asadollahi, Parisa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Brucella |
|---|
| Anmerkungen: |
Date Completed 09.03.2023 Date Revised 15.07.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1570163819666220805161821 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM344491617 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM344491617 | ||
| 003 | DE-627 | ||
| 005 | 20231226022908.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1570163819666220805161821 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1148.xml |
| 035 | |a (DE-627)NLM344491617 | ||
| 035 | |a (NLM)35929636 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Asadollahi, Parisa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a In silico Study of the Proteins Involved in the Persistence of Brucella spp |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.03.2023 | ||
| 500 | |a Date Revised 15.07.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a BACKGROUND: One of the major problems with Brucella infections is its tendency to become chronic and recurrent, providing a hindrance to the management of this infection. It has been proposed that chronicity is greatly affected by a phenomenon called persistence in bacteria. Several mechanisms are involved in bacterial persistence, including the type II toxin-antitoxin system, the SOS and oxidative and stringent responses | ||
| 520 | |a METHODS: In this in silico study, these persistence mechanisms in Brucella spp. were investigated | ||
| 520 | |a RESULTS: The structure and the interactions between modules involved in these systems were designed, and novel peptides that can interfere with some of these important mechanisms were developed | ||
| 520 | |a CONCLUSION: Since peptide-based therapeutics are a new and evolving field due to their ease of production, we hope that peptides developed in this study, as well as the information about the structure and interactions of modules of persistence mechanisms, can further be used to design drugs against Brucella persister cells in the hope of restraining the chronic nature of Brucellosis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Brucella | |
| 650 | 4 | |a brucellosis | |
| 650 | 4 | |a in silico | |
| 650 | 4 | |a inhibitory peptides | |
| 650 | 4 | |a protein interaction | |
| 650 | 4 | |a zoonotic febrile disease | |
| 650 | 7 | |a Peptides |2 NLM | |
| 700 | 1 | |a Sadeghifard, Nourkhoda |e verfasserin |4 aut | |
| 700 | 1 | |a Kazemian, Hossein |e verfasserin |4 aut | |
| 700 | 1 | |a Pakzad, Iraj |e verfasserin |4 aut | |
| 700 | 1 | |a Kalani, Behrooz Sadeghi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current drug discovery technologies |d 2004 |g 20(2023), 1 vom: 05., Seite e050822207324 |w (DE-627)NLM160661455 |x 1875-6220 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2023 |g number:1 |g day:05 |g pages:e050822207324 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1570163819666220805161821 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2023 |e 1 |b 05 |h e050822207324 | ||